Skip to main content
Top
Published in: Neuroradiology 8/2013

01-08-2013 | Diagnostic Neuroradiology

Correlation between pathology and neuromelanin MR imaging in Parkinson’s disease and dementia with Lewy bodies

Authors: Shinichiro Kitao, Eiji Matsusue, Shinya Fujii, Fuminori Miyoshi, Toshio Kaminou, Shinsuke Kato, Hisao Ito, Toshihide Ogawa

Published in: Neuroradiology | Issue 8/2013

Login to get access

Abstract

Introduction

Direct correlation between neuropathological findings and postmortem neuromelanin MR imaging (NmMRI) was performed in the substantia nigra pars compacta (SNc) to clarify the pathological background of the signal changes in normal, Parkinson’s disease (PD), and dementia with Lewy bodies (DLB) cases.

Methods

NmMRI of 10 % formalin-fixed autopsied midbrains was performed in three cases (normal control, DLB, and PD) with a 3T imaging system, using a 3D gradient echo T1-weighted sequence with a magnetization transfer contrast pulse. Neuropathological examinations of the midbrains were performed, and the density of neuromelanin-positive neurons (number per square millimeter) was determined. The extent of iron deposition in the midbrain was also evaluated using ferritin immunohistochemistry. Furthermore, we directly correlated the contrast signal ratio in the SNc and the density of neuromelanin-containing neurons.

Results

Diffuse hyperintense areas in the SNc reflected well-preserved neuromelanin-containing neurons in the normal control case, whereas an iso-intense area in the SNc showed severe loss of neuromelanin-containing neurons in the DLB and PD cases. Increased signal intensity in the SNc was apparently not influenced by iron deposition. Furthermore, a significant positive correlation between signal intensity and the density of neuromelanin-containing neurons was seen in the SNc.

Conclusion

Based on the direct correlation between postportem NmMRI and neuropathological findings, signal intensity in the SNc is closely related to the quantity of neuromelanin-containing neurons but is not influenced by iron deposition.
Literature
1.
go back to reference Marsden D (1965) Brain pigment and its relation to brain catecholamines. Lancet 10:475–76CrossRef Marsden D (1965) Brain pigment and its relation to brain catecholamines. Lancet 10:475–76CrossRef
2.
go back to reference Graham DG (1979) On the origin and significance of neuromelanin. Arch Pathol Lab Med 103:359–62PubMed Graham DG (1979) On the origin and significance of neuromelanin. Arch Pathol Lab Med 103:359–62PubMed
3.
go back to reference Bazelon M, Fenichel GM, Randall J (1967) Studies on neuromelanin: I. A melanin system in the human adult brainstem. Neurology 17:512–18PubMedCrossRef Bazelon M, Fenichel GM, Randall J (1967) Studies on neuromelanin: I. A melanin system in the human adult brainstem. Neurology 17:512–18PubMedCrossRef
4.
go back to reference Enochs WS, Hyslop WB, Bennett HF et al (1997) Sources of the increased longitudinal relaxation rates observed in melanotic melanoma: an in vitro study of synthetic melanins. Invest Radiol 24:794–804CrossRef Enochs WS, Hyslop WB, Bennett HF et al (1997) Sources of the increased longitudinal relaxation rates observed in melanotic melanoma: an in vitro study of synthetic melanins. Invest Radiol 24:794–804CrossRef
5.
go back to reference Enochs WS, Petherick P, Bogdanova A et al (1997) Paramagnetic metal scavenging by melanin: MR imaging. Radiology 204:417–23PubMed Enochs WS, Petherick P, Bogdanova A et al (1997) Paramagnetic metal scavenging by melanin: MR imaging. Radiology 204:417–23PubMed
6.
go back to reference Sasaki M, Shibata E, Tohyama K et al (2006) Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson’s disease. Neuroreport 17:1215–8PubMedCrossRef Sasaki M, Shibata E, Tohyama K et al (2006) Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson’s disease. Neuroreport 17:1215–8PubMedCrossRef
7.
go back to reference Nakane T, Nihashi T, Kawai H et al (2008) Visualization of neuromelanin in the substantia nigra and locus ceruleus at 1.5T using a 3D-gradient echo sequence with magnetization transfer contrast. Magn Reson Med Sci 7:205–10PubMedCrossRef Nakane T, Nihashi T, Kawai H et al (2008) Visualization of neuromelanin in the substantia nigra and locus ceruleus at 1.5T using a 3D-gradient echo sequence with magnetization transfer contrast. Magn Reson Med Sci 7:205–10PubMedCrossRef
8.
go back to reference McKeith IG, Galasko D, Kosaka K et al (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB International Workshop. Neurology 47:1113–24PubMedCrossRef McKeith IG, Galasko D, Kosaka K et al (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB International Workshop. Neurology 47:1113–24PubMedCrossRef
9.
go back to reference McKeith IG, Dickson DW, Lowe J et al (2005) Consortium on DLB: diagnosis and management of dementia with Lewy bodies: third report of the DLB consortium. Neurology 65:1863–72PubMedCrossRef McKeith IG, Dickson DW, Lowe J et al (2005) Consortium on DLB: diagnosis and management of dementia with Lewy bodies: third report of the DLB consortium. Neurology 65:1863–72PubMedCrossRef
10.
go back to reference Schwarz ST, Rittman T et al (2011) T1-weighted MRI shows stage-dependent substantia nigra signal loss in Parkinson’s disease. Movement Disorders 29:1633–38CrossRef Schwarz ST, Rittman T et al (2011) T1-weighted MRI shows stage-dependent substantia nigra signal loss in Parkinson’s disease. Movement Disorders 29:1633–38CrossRef
11.
go back to reference Hallgren B, Sourander P (1958) The effect of age of the non/hemin iron in the human brain. J Neurochem 3:41–51PubMedCrossRef Hallgren B, Sourander P (1958) The effect of age of the non/hemin iron in the human brain. J Neurochem 3:41–51PubMedCrossRef
12.
go back to reference Vymazal J, Righini A, Brooks RA et al (1999) T1 and T2 in the brain of healthy subjects, patients with Parkinson disease, and patients with Parkinson disease, and patients with multiple system atrophy: relation of iron content. Radiology 211:489–95PubMed Vymazal J, Righini A, Brooks RA et al (1999) T1 and T2 in the brain of healthy subjects, patients with Parkinson disease, and patients with Parkinson disease, and patients with multiple system atrophy: relation of iron content. Radiology 211:489–95PubMed
13.
go back to reference Kinoshita T, Ogawa T, Yoshida Y et al (2005) Curvilinear T1 hyperintense lesions representing cortical necrosis after cerebral infarction. Neuroradiology 47:647–51PubMedCrossRef Kinoshita T, Ogawa T, Yoshida Y et al (2005) Curvilinear T1 hyperintense lesions representing cortical necrosis after cerebral infarction. Neuroradiology 47:647–51PubMedCrossRef
14.
go back to reference Castillo M, Scatliff JH, Kwock L et al (1996) Postmortem MR imaging of lobar cerebral infarction with pathologic and in vivo correlation. Radiographics 16:241–50PubMed Castillo M, Scatliff JH, Kwock L et al (1996) Postmortem MR imaging of lobar cerebral infarction with pathologic and in vivo correlation. Radiographics 16:241–50PubMed
15.
go back to reference van den Hauwe L, Parizel PM, Martin JJ et al (1995) Postmortem MRI of the brain with neuropathological correlation. Neuroradiology 37:343–9PubMedCrossRef van den Hauwe L, Parizel PM, Martin JJ et al (1995) Postmortem MRI of the brain with neuropathological correlation. Neuroradiology 37:343–9PubMedCrossRef
16.
go back to reference Tovi M, Ericsson A (1992) Measurements of T1 and T2 over time in formalin-fixed human whole-brain specimens. Acta Radiol 33:400–4PubMed Tovi M, Ericsson A (1992) Measurements of T1 and T2 over time in formalin-fixed human whole-brain specimens. Acta Radiol 33:400–4PubMed
17.
go back to reference Kashihara K, Shinya T, Higaki F (2011) Neuromelanin magnetic resonance imaging of nigral volume loss in patients with Parkinson's disease. J Clin Neurosci 18:1093–6PubMedCrossRef Kashihara K, Shinya T, Higaki F (2011) Neuromelanin magnetic resonance imaging of nigral volume loss in patients with Parkinson's disease. J Clin Neurosci 18:1093–6PubMedCrossRef
18.
go back to reference Kashihara K, Shinya T, Higaki F (2011) Reduction of neuromelanin-positive nigral volume in patients with MSA, PSP and CBD. Intern Med 50:1683–7PubMedCrossRef Kashihara K, Shinya T, Higaki F (2011) Reduction of neuromelanin-positive nigral volume in patients with MSA, PSP and CBD. Intern Med 50:1683–7PubMedCrossRef
Metadata
Title
Correlation between pathology and neuromelanin MR imaging in Parkinson’s disease and dementia with Lewy bodies
Authors
Shinichiro Kitao
Eiji Matsusue
Shinya Fujii
Fuminori Miyoshi
Toshio Kaminou
Shinsuke Kato
Hisao Ito
Toshihide Ogawa
Publication date
01-08-2013
Publisher
Springer Berlin Heidelberg
Published in
Neuroradiology / Issue 8/2013
Print ISSN: 0028-3940
Electronic ISSN: 1432-1920
DOI
https://doi.org/10.1007/s00234-013-1199-9

Other articles of this Issue 8/2013

Neuroradiology 8/2013 Go to the issue